Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway
BackgroundBreast cancer has now become the most prevalent cancer worldwide. Existing therapeutic agents are generally accompanied by significant side effects. Here, we highlight Saikosaponin A (SSA), a promising natural metabolite characterized by low toxicity, demonstrating significant efficacy aga...
Saved in:
| Main Authors: | Yingchao Wu, Liushan Chen, Dajin Pi, Jiaqi Cui, Yuqi Liang, Peng Wu, Mingzi Ouyang, Qian Zuo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1532579/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Senkyunolide H reverses depression-induced breast cancer progression by regulating CXCR2
by: Yingchao Wu, et al.
Published: (2025-08-01) -
Exploring the predictive “psycho-biomarkers” for checkpoint immunotherapy in cancer
by: Qian Zuo, et al.
Published: (2025-07-01) -
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p
by: Liushan Chen, et al.
Published: (2024-12-01) -
Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach
by: Huiling Wei, et al.
Published: (2025-01-01) -
Pharmacology, medical uses, and clinical translational challenges of Saikosaponin A: A review
by: Xiao-Hong Sun, et al.
Published: (2024-11-01)